Mengyuan Ge

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Mengyuan Ge, Judith Molina, Ian Tamayo, Guanshi Zhang, Jin-Ju Kim, Rachel Njeim, Flavia Fontanesi, Michael Paul Pieper, Sandra Merscher, Kumar Sharma, Alessia Fornoni
Metabolic Analysis and Renal Protective Effects of Linagliptin and Empagliflozin in Alport Syndrome. Kidney360 5 (7) (2024)
Mengyuan Ge, Judith Molina, Ian Tamayo, Guanshi Zhang, Jin-Ju Kim, Rachel Njeim, Flavia Fontanesi, Michael Paul Pieper, Sandra Merscher, Kumar Sharma, Alessia Fornoni
Metabolic Analysis and Renal Protective Effects of Linagliptin and Empagliflozin in Alport Syndrome. Kidney360 (2024)
Mengyuan Ge, Judith Molina, Ian Tamayo, Guanshi Zhang, Jin-Ju Kim, Rachel Njeim, Flavia Fontanesi, Michael Paul Pieper, Sandra Merscher, Kumar Sharma, Alessia Fornoni
Metabolic Analysis and Renal Protective Effects of Linagliptin and Empagliflozin in Alport Syndrome. Kidney360 5 (7) (2024)
Mengyuan Ge, Judith Molina, Ian Tamayo, Guanshi Zhang, Jin-Ju Kim, Rachel Njeim, Flavia Fontanesi, Michael Paul Pieper, Sandra Merscher, Kumar Sharma, Alessia Fornoni
Metabolic Analysis and Renal Protective Effects of Linagliptin and Empagliflozin in Alport Syndrome. Kidney360 5 (7) (2024)
Mengyuan Ge, Judith Molina, Ian Tamayo, Guanshi Zhang, Jin-Ju Kim, Rachel Njeim, Flavia Fontanesi, Michael Paul Pieper, Sandra Merscher, Kumar Sharma, Alessia Fornoni
Metabolic Analysis and Renal Protective Effects of Linagliptin and Empagliflozin in Alport Syndrome. Kidney360 5 (7) (2024)